Rijksinstituut voor Volksgezondheid en Milieu
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021. | RIVM
Bron:
rivm.nl